Genome & Company (KOSDAQ:314130)

Genome & Company Statistics

Total Valuation

KOSDAQ:314130 has a market cap or net worth of KRW 83.78 billion. The enterprise value is 77.83 billion.

Market Cap	83.78B
Enterprise Value	77.83B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:314130 has 31.09 million shares outstanding. The number of shares has increased by 5.98% in one year.

Current Share Class	31.09M
Shares Outstanding	31.09M
Shares Change (YoY)	+5.98%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	20.78%
Owned by Institutions (%)	17.55%
Float	21.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.49
PB Ratio	0.82
P/TBV Ratio	1.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.87
EV / Sales	3.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.81

Financial Position

The company has a current ratio of 2.99, with a Debt / Equity ratio of 0.27.

Current Ratio	2.99
Quick Ratio	2.67
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	-1.34
Interest Coverage	-6.17

Financial Efficiency

Return on equity (ROE) is -30.76% and return on invested capital (ROIC) is -12.64%.

Return on Equity (ROE)	-30.76%
Return on Assets (ROA)	-11.34%
Return on Invested Capital (ROIC)	-12.64%
Return on Capital Employed (ROCE)	-22.84%
Revenue Per Employee	247.61M
Profits Per Employee	-279.20M
Employee Count	97
Asset Turnover	0.16
Inventory Turnover	1.96

Taxes

Income Tax	-692.20M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.27% in the last 52 weeks. The beta is 1.12, so KOSDAQ:314130's price volatility has been higher than the market average.

Beta (5Y)	1.12
52-Week Price Change	-25.27%
50-Day Moving Average	2,748.10
200-Day Moving Average	2,725.50
Relative Strength Index (RSI)	48.13
Average Volume (20 Days)	96,641

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:314130 had revenue of KRW 24.02 billion and -27.08 billion in losses. Loss per share was -875.42.

Revenue	24.02B
Gross Profit	13.09B
Operating Income	-27.28B
Pretax Income	-33.69B
Net Income	-27.08B
EBITDA	-19.82B
EBIT	-27.28B
Loss Per Share	-875.42

Balance Sheet

The company has 59.29 billion in cash and 27.43 billion in debt, giving a net cash position of 31.86 billion or 1,024.79 per share.

Cash & Cash Equivalents	59.29B
Total Debt	27.43B
Net Cash	31.86B
Net Cash Per Share	1,024.79
Equity (Book Value)	102.07B
Book Value Per Share	2,449.79
Working Capital	45.66B

Cash Flow

In the last 12 months, operating cash flow was -18.98 billion and capital expenditures -1.47 billion, giving a free cash flow of -20.45 billion.

Operating Cash Flow	-18.98B
Capital Expenditures	-1.47B
Free Cash Flow	-20.45B
FCF Per Share	-657.76

Margins

Gross margin is 54.49%, with operating and profit margins of -113.56% and -112.76%.

Gross Margin	54.49%
Operating Margin	-113.56%
Pretax Margin	-140.26%
Profit Margin	-112.76%
EBITDA Margin	-82.51%
EBIT Margin	-113.56%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:314130 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.98%
Shareholder Yield	n/a
Earnings Yield	-32.33%
FCF Yield	-24.41%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 6, 2024. It was a forward split with a ratio of 2.

Last Split Date	Aug 6, 2024
Split Type	Forward
Split Ratio	2

Scores

KOSDAQ:314130 has an Altman Z-Score of -1.72 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.72
Piotroski F-Score	4